<?xml version="1.0" encoding="utf-8"?>
<Return xmlns="http://www.irs.gov/efile" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" returnVersion="2023v5.0">
  <ReturnHeader binaryAttachmentCnt="0">
    <ReturnTs>2024-06-17T20:14:12-04:00</ReturnTs>
    <TaxPeriodEndDt>2023-12-31</TaxPeriodEndDt>
    <PreparerFirmGrp>
      <PreparerFirmEIN>263941216</PreparerFirmEIN>
      <PreparerFirmName>
        <BusinessNameLine1Txt>M W ORLANDO CPA INC</BusinessNameLine1Txt>
      </PreparerFirmName>
      <PreparerUSAddress>
        <AddressLine1Txt>1902 WRIGHT PLACE 2ND FLOOR</AddressLine1Txt>
        <CityNm>CARLSBAD</CityNm>
        <StateAbbreviationCd>CA</StateAbbreviationCd>
        <ZIPCd>92008</ZIPCd>
      </PreparerUSAddress>
    </PreparerFirmGrp>
    <ReturnTypeCd>990EZ</ReturnTypeCd>
    <TaxPeriodBeginDt>2023-01-01</TaxPeriodBeginDt>
    <Filer>
      <EIN>263728931</EIN>
      <BusinessName>
        <BusinessNameLine1Txt>PEPTIDE THERAPEUTICS FOUNDATION</BusinessNameLine1Txt>
      </BusinessName>
      <BusinessNameControlTxt>PEPT</BusinessNameControlTxt>
      <PhoneNum>8586571511</PhoneNum>
      <USAddress>
        <AddressLine1Txt>9395 CABOT DRIVE</AddressLine1Txt>
        <CityNm>SAN DIEGO</CityNm>
        <StateAbbreviationCd>CA</StateAbbreviationCd>
        <ZIPCd>92126</ZIPCd>
      </USAddress>
    </Filer>
    <BusinessOfficerGrp>
      <PersonNm>ADRIENNE DAY PHD</PersonNm>
      <PersonTitleTxt>TREASURE &amp; BOARD DIR</PersonTitleTxt>
      <PhoneNum>8586571511</PhoneNum>
      <SignatureDt>2024-06-11</SignatureDt>
      <DiscussWithPaidPreparerInd>true</DiscussWithPaidPreparerInd>
    </BusinessOfficerGrp>
    <SigningOfficerGrp>
      <PersonFullName>
        <PersonFirstNm>ADRIENNE</PersonFirstNm>
        <PersonLastNm>DAY</PersonLastNm>
      </PersonFullName>
      <SSN>XXX-XX-XXXX</SSN>
    </SigningOfficerGrp>
    <IRSResponsiblePrtyInfoCurrInd>false</IRSResponsiblePrtyInfoCurrInd>
    <PreparerPersonGrp>
      <PreparerPersonNm>MARK W ORLANDO CPA</PreparerPersonNm>
      <PTIN>P00752621</PTIN>
      <PhoneNum>7603312975</PhoneNum>
      <PreparationDt>2024-06-11</PreparationDt>
      <SelfEmployedInd>X</SelfEmployedInd>
    </PreparerPersonGrp>
    <TaxYr>2023</TaxYr>
    <BuildTS>2023-04-26 12:10:37Z</BuildTS>
  </ReturnHeader>
  <ReturnData documentCnt="3">
    <IRS990EZ documentId="RetDoc1" referenceDocumentId="RetDoc2">
      <MethodOfAccountingAccrualInd>X</MethodOfAccountingAccrualInd>
      <ScheduleBNotRequiredInd>X</ScheduleBNotRequiredInd>
      <WebsiteAddressTxt>WWW.PEPTIDETHERAPEUTICS.ORG</WebsiteAddressTxt>
      <Organization501c3Ind referenceDocumentId="RetDoc3">X</Organization501c3Ind>
      <TypeOfOrganizationCorpInd>X</TypeOfOrganizationCorpInd>
      <GrossReceiptsAmt>134883</GrossReceiptsAmt>
      <InfoInScheduleOPartIInd>X</InfoInScheduleOPartIInd>
      <MembershipDuesAmt>134883</MembershipDuesAmt>
      <TotalRevenueAmt>134883</TotalRevenueAmt>
      <OtherExpensesTotalAmt>157903</OtherExpensesTotalAmt>
      <TotalExpensesAmt>157903</TotalExpensesAmt>
      <ExcessOrDeficitForYearAmt>-23020</ExcessOrDeficitForYearAmt>
      <NetAssetsOrFundBalancesBOYAmt>281243</NetAssetsOrFundBalancesBOYAmt>
      <OtherChangesInNetAssetsAmt>28721</OtherChangesInNetAssetsAmt>
      <NetAssetsOrFundBalancesEOYAmt>286944</NetAssetsOrFundBalancesEOYAmt>
      <InfoInScheduleOPartIIInd>X</InfoInScheduleOPartIIInd>
      <CashSavingsAndInvestmentsGrp>
        <BOYAmt>281743</BOYAmt>
        <EOYAmt>286944</EOYAmt>
      </CashSavingsAndInvestmentsGrp>
      <Form990TotalAssetsGrp>
        <BOYAmt>281743</BOYAmt>
        <EOYAmt>286944</EOYAmt>
      </Form990TotalAssetsGrp>
      <SumOfTotalLiabilitiesGrp>
        <BOYAmt>500</BOYAmt>
      </SumOfTotalLiabilitiesGrp>
      <NetAssetsOrFundBalancesGrp>
        <BOYAmt>281243</BOYAmt>
        <EOYAmt>286944</EOYAmt>
      </NetAssetsOrFundBalancesGrp>
      <InfoInScheduleOPartIIIInd>X</InfoInScheduleOPartIIIInd>
      <PrimaryExemptPurposeTxt>THE MISSION OF PEPTIDE THERAPEUTICS FOUNDATION IS TO PROVIDE AND PROMOTE PUBLIC AND CHARITABLE EDUCATIONAL AND INFORMATION PROGRAMS, MATERIALS, RESEARCH AND DISCUSSION IN THE MEDICAL SCIENTIFIC FIELD OF PEPTIDE SCIENCE AND TECHNOLOGY.</PrimaryExemptPurposeTxt>
      <ProgramSrvcAccomplishmentGrp>
        <DescriptionProgramSrvcAccomTxt>HOLD A PEPTIDE THERAPEUTICS SYMPOSIUM TO BRING TOGETHER WORLD LEADERS FROM ACADEMIA, THE BIOPHARMACEUTICAL INDUSTRY, CMOS, CROS, AND INVESTORS INTERESTED IN ALL ASPECTS OF PEPTIDE R&amp;D, INCLUDING DRUG DISCOVERY, SAFETY AND TOXICOLOGY, CLINICAL DEVELOMENT, MANUFACTURING, PHARMACEUTICAL DEVELOPMENT, FORMULATION, DRUG DELIVERY AND REGULATORY AFFAIRS. THE ORGANIZATION ALSO PROVIDED 13 POSTDOCTORAL FELLOWS AND GRADUATE STUDENTS WITH FREE REGISTRATION TO THE SYMPOSIUM.</DescriptionProgramSrvcAccomTxt>
        <ProgramServiceExpensesAmt>156959</ProgramServiceExpensesAmt>
      </ProgramSrvcAccomplishmentGrp>
      <ProgramSrvcAccomplishmentGrp>
        <DescriptionProgramSrvcAccomTxt>PEPTIDE THERAPEUTICS HAS ASSETS IN AN A BROKERAGE FIRM. EXPENSES ARE RELATED TO THE BROKERAGE FIRM.</DescriptionProgramSrvcAccomTxt>
        <ProgramServiceExpensesAmt>944</ProgramServiceExpensesAmt>
      </ProgramSrvcAccomplishmentGrp>
      <TotalProgramServiceExpensesAmt>157903</TotalProgramServiceExpensesAmt>
      <OfficerDirectorTrusteeEmplGrp>
        <PersonNm>PHIL DAWSON PHD</PersonNm>
        <TitleTxt>CHAIRMAN OF</TitleTxt>
        <AverageHrsPerWkDevotedToPosRt>1.00</AverageHrsPerWkDevotedToPosRt>
        <CompensationAmt>0</CompensationAmt>
      </OfficerDirectorTrusteeEmplGrp>
      <OfficerDirectorTrusteeEmplGrp>
        <PersonNm>ADAM MEZO PHD</PersonNm>
        <TitleTxt>PRESIDENT</TitleTxt>
        <AverageHrsPerWkDevotedToPosRt>1.00</AverageHrsPerWkDevotedToPosRt>
        <CompensationAmt>0</CompensationAmt>
      </OfficerDirectorTrusteeEmplGrp>
      <OfficerDirectorTrusteeEmplGrp>
        <PersonNm>NICK COX PHD</PersonNm>
        <TitleTxt>SECRETARY</TitleTxt>
        <AverageHrsPerWkDevotedToPosRt>1.00</AverageHrsPerWkDevotedToPosRt>
        <CompensationAmt>0</CompensationAmt>
      </OfficerDirectorTrusteeEmplGrp>
      <OfficerDirectorTrusteeEmplGrp>
        <PersonNm>ADRIENNE DAY PHD</PersonNm>
        <TitleTxt>TREASURE &amp; B</TitleTxt>
        <AverageHrsPerWkDevotedToPosRt>1.00</AverageHrsPerWkDevotedToPosRt>
        <CompensationAmt>0</CompensationAmt>
      </OfficerDirectorTrusteeEmplGrp>
      <ActivitiesNotPreviouslyRptInd>false</ActivitiesNotPreviouslyRptInd>
      <ChgMadeToOrgnzngDocNotRptInd>false</ChgMadeToOrgnzngDocNotRptInd>
      <OrganizationHadUBIInd>false</OrganizationHadUBIInd>
      <SubjectToProxyTaxInd>false</SubjectToProxyTaxInd>
      <OrganizationDissolvedEtcInd>false</OrganizationDissolvedEtcInd>
      <Form1120PolFiledInd>false</Form1120PolFiledInd>
      <MadeLoansToFromOfficersInd>false</MadeLoansToFromOfficersInd>
      <EngagedInExcessBenefitTransInd>false</EngagedInExcessBenefitTransInd>
      <ProhibitedTaxShelterTransInd>false</ProhibitedTaxShelterTransInd>
      <StatesWhereCopyOfReturnIsFldCd>CA</StatesWhereCopyOfReturnIsFldCd>
      <BooksInCareOfDetail>
        <BusinessName>
          <BusinessNameLine1Txt>BLUE GUM ADVISORS LLC</BusinessNameLine1Txt>
        </BusinessName>
        <USAddress>
          <AddressLine1Txt>3529 BANCROFT ST</AddressLine1Txt>
          <CityNm>SAN DIEGO</CityNm>
          <StateAbbreviationCd>CA</StateAbbreviationCd>
          <ZIPCd>92104</ZIPCd>
        </USAddress>
        <PhoneNum>8586571511</PhoneNum>
      </BooksInCareOfDetail>
      <ForeignFinancialAccountInd>false</ForeignFinancialAccountInd>
      <ForeignOfficeInd>false</ForeignOfficeInd>
      <DonorAdvisedFndsInd>false</DonorAdvisedFndsInd>
      <OperateHospitalInd>false</OperateHospitalInd>
      <TanningServicesProvidedInd>false</TanningServicesProvidedInd>
      <RelatedOrganizationCtrlEntInd>false</RelatedOrganizationCtrlEntInd>
      <TransactionWithControlEntInd>false</TransactionWithControlEntInd>
      <PoliticalCampaignActyInd>false</PoliticalCampaignActyInd>
      <LobbyingActivitiesInd>false</LobbyingActivitiesInd>
      <SchoolOperatingInd>false</SchoolOperatingInd>
      <TrnsfrExmptNonChrtblRltdOrgInd>false</TrnsfrExmptNonChrtblRltdOrgInd>
      <PartVIOfCompOfHghstPdEmplTxt>NONE</PartVIOfCompOfHghstPdEmplTxt>
      <PartVIHghstPdCntrctProfSrvcTxt>NONE</PartVIHghstPdCntrctProfSrvcTxt>
      <FiledScheduleAInd>true</FiledScheduleAInd>
    </IRS990EZ>
    <IRS990ScheduleA documentId="RetDoc3">
      <PubliclySupportedOrg509a2Ind>X</PubliclySupportedOrg509a2Ind>
      <GiftsGrantsContrisRcvd509Grp>
        <CurrentTaxYearMinus4YearsAmt>89945</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>43680</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>50160</CurrentTaxYearMinus2YearsAmt>
        <TotalAmt>183785</TotalAmt>
      </GiftsGrantsContrisRcvd509Grp>
      <GrossReceiptsAdmissionsGrp>
        <CurrentTaxYearMinus4YearsAmt>31320</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>6200</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>20180</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>102509</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>134883</CurrentTaxYearAmt>
        <TotalAmt>295092</TotalAmt>
      </GrossReceiptsAdmissionsGrp>
      <Total509Grp>
        <CurrentTaxYearMinus4YearsAmt>121265</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>49880</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>70340</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>102509</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>134883</CurrentTaxYearAmt>
        <TotalAmt>478877</TotalAmt>
      </Total509Grp>
      <PublicSupportTotal509Amt>478877</PublicSupportTotal509Amt>
      <GrossInvestmentIncome509Grp>
        <CurrentTaxYearAmt>3</CurrentTaxYearAmt>
        <TotalAmt>3</TotalAmt>
      </GrossInvestmentIncome509Grp>
      <InvestmentIncomeAndUBTIGrp>
        <CurrentTaxYearAmt>3</CurrentTaxYearAmt>
        <TotalAmt>3</TotalAmt>
      </InvestmentIncomeAndUBTIGrp>
      <TotalSupportCalendarYearGrp>
        <CurrentTaxYearMinus4YearsAmt>121265</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>49880</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>70340</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>102509</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>134886</CurrentTaxYearAmt>
        <TotalAmt>478880</TotalAmt>
      </TotalSupportCalendarYearGrp>
      <PublicSupportCY509Pct>1.00000</PublicSupportCY509Pct>
      <PublicSupportPY509Pct>0.96770</PublicSupportPY509Pct>
      <InvestmentIncomeCYPct>0.00000</InvestmentIncomeCYPct>
      <InvestmentIncomePYPct>0.03000</InvestmentIncomePYPct>
      <ThirtyThrPctSuprtTestsCY509Ind>X</ThirtyThrPctSuprtTestsCY509Ind>
    </IRS990ScheduleA>
    <IRS990ScheduleO documentId="RetDoc2">
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990-EZ, PART I, LINE 16</FormAndLineReferenceDesc>
        <ExplanationTxt>EXPENSES 944 ACCOUNTING 1,655 ADMINISTRATION FEES 25,590 CONTRACT SERVICES 720 DUES AND SUBSCRIPTIONS 189 LICENSES AND FEES 1,199 MEALS AND ENTERTAINMENT 23 SUPPLIES 173 SYMPOSIUM EXPENSES 127,410 TOTAL 157,903</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990-EZ, PART I, LINE 20</FormAndLineReferenceDesc>
        <ExplanationTxt>UNREALIZED GAIN ON INVESTMENTS 28,721</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990-EZ, PART II, LINE 26</FormAndLineReferenceDesc>
        <ExplanationTxt>ACCRUED SYMPOSIUM EXPENSE 500 0</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990-EZ, PART III</FormAndLineReferenceDesc>
        <ExplanationTxt>THE MISSION OF PEPTIDE THERAPEUTICS FOUNDATION IS TO PROVIDE AND PROMOTE PUBLIC AND CHARITABLE EDUCATIONAL AND INFORMATION PROGRAMS, MATERIALS, RESEARCH AND DISCUSSION IN THE MEDICAL SCIENTIFIC FIELD OF PEPTIDE SCIENCE AND TECHNOLOGY.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990-EZ, PART III, LINE 28</FormAndLineReferenceDesc>
        <ExplanationTxt>HOLD A PEPTIDE THERAPEUTICS SYMPOSIUM TO BRING TOGETHER WORLD LEADERS FROM ACADEMIA, THE BIOPHARMACEUTICAL INDUSTRY, CMOS, CROS, AND INVESTORS INTERESTED IN ALL ASPECTS OF PEPTIDE R&amp;D, INCLUDING DRUG DISCOVERY, SAFETY AND TOXICOLOGY, CLINICAL DEVELOMENT, MANUFACTURING, PHARMACEUTICAL DEVELOPMENT, FORMULATION, DRUG DELIVERY AND REGULATORY AFFAIRS. THE ORGANIZATION ALSO PROVIDED 13 POSTDOCTORAL FELLOWS AND GRADUATE STUDENTS WITH FREE REGISTRATION TO THE SYMPOSIUM.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990-EZ, PART III, LINE 31</FormAndLineReferenceDesc>
        <ExplanationTxt>PEPTIDE THERAPEUTICS HAS ASSETS IN AN A BROKERAGE FIRM. EXPENSES ARE RELATED TO THE BROKERAGE FIRM.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleO>
  </ReturnData>
</Return>
